Gallentes, Lyca L.

HRN: 19-25-64  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2022
CEFUROXIME 1.5GM (VIAL)
07/21/2022
07/28/2022
IVT
1.5gm
Q8H
G2P1 (1001) IUFD, UTI
Waiting Final Action 
07/22/2022
CEFUROXIME 500MG (TAB)
07/22/2022
07/29/2022
ORAL
500mg
Q12
S/P NSVD IUFD
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: